热门资讯> 正文

Maravai LifeSciences通过1.8亿美元的信贷安排对债务进行再融资;降低未偿借款

2026-06-03 21:45

Maravai Lifesciences Holdings, Inc. Class A(MRVI) 0

Maravai LifeSciences (MRVI) announced on Wednesday that its subsidiaries signed a new credit agreement including a $150M term loan facility and a $30M revolving credit facility.
The company used the new loan and about $98.5M in cash to repay debt under its previous credit agreement due in October 2027.
The refinancing cuts the company's long-term debt to $150M from about $242.9M and extends the maturity to June 2032, while keeping additional liquidity available for future growth.
Source: Press Release

More on Maravai LifeSciences Holdings

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation
Maravai LifeSciences Holdings GAAP EPS of -$0.02 beats by $0.07, revenue of $65.8M beats by $12.8M
Maravai LifeSciences Holdings Q1 2026 Earnings Preview

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。